| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Abrogation of radioresistance in glioblastoma stem-like cells by inhibition of ATM kinase
|
Carruthers, Ross
|
|
2015
|
|
1 |
p. 192-203
12 p.
|
artikel
|
| 2 |
Accumulation of genomic alterations in 2p16, 9q33.1 and 19p13 in lung tumours of asbestos-exposed patients
|
Nymark, Penny
|
|
2013
|
|
1 |
p. 29-40
12 p.
|
artikel
|
| 3 |
Acid ceramidase is associated with an improved prognosis in both DCIS and invasive breast cancer
|
Sänger, Nicole
|
|
2015
|
|
1 |
p. 58-67
10 p.
|
artikel
|
| 4 |
Additive impact of HER2-/PTK6-RNAi on interactions with HER3 or IGF-1R leads to reduced breast cancer progression in vivo
|
Falkenberg, Natalie
|
|
2015
|
|
1 |
p. 282-294
13 p.
|
artikel
|
| 5 |
Aldehyde dehydrogenase 1A3 influences breast cancer progression via differential retinoic acid signaling
|
Marcato, Paola
|
|
2015
|
|
1 |
p. 17-31
15 p.
|
artikel
|
| 6 |
ALDH-1 expression levels predict response or resistance to preoperative chemoradiation in resectable esophageal cancer patients
|
Ajani, J.A.
|
|
2014
|
|
1 |
p. 142-149
8 p.
|
artikel
|
| 7 |
Altered purinergic receptor-Ca2+ signaling associated with hypoxia-induced epithelial-mesenchymal transition in breast cancer cells
|
Azimi, Iman
|
|
2016
|
|
1 |
p. 166-178
13 p.
|
artikel
|
| 8 |
Alternative splicing of TIA-1 in human colon cancer regulates VEGF isoform expression, angiogenesis, tumour growth and bevacizumab resistance
|
Hamdollah Zadeh, Maryam A.
|
|
2015
|
|
1 |
p. 167-178
12 p.
|
artikel
|
| 9 |
American Society of Clinical Oncology's 2008 Gastrointestinal Cancers Symposium (ASCO GI), January 25–27, 2008, Orlando, Florida
|
Fricker, Janet
|
|
2008
|
|
1 |
p. 5-7
3 p.
|
artikel
|
| 10 |
An integrative framework identifies alternative splicing events in colorectal cancer development
|
Bisognin, Andrea
|
|
2014
|
|
1 |
p. 129-141
13 p.
|
artikel
|
| 11 |
Aquaporins mediate the chemoresistance of human melanoma cells to arsenite
|
Gao, Lin
|
|
2012
|
|
1 |
p. 81-87
7 p.
|
artikel
|
| 12 |
A role for p38 MAPK in head and neck cancer cell growth and tumor-induced angiogenesis and lymphangiogenesis
|
Leelahavanichkul, Kantima
|
|
2014
|
|
1 |
p. 105-118
14 p.
|
artikel
|
| 13 |
Atorvastatin reduces vascular endothelial growth factor (VEGF) expression in human non-small cell lung carcinomas (NSCLCs) via inhibition of reactive oxygen species (ROS) production
|
Chen, Jie
|
|
2012
|
|
1 |
p. 62-72
11 p.
|
artikel
|
| 14 |
A tumor DNA complex aberration index is an independent predictor of survival in breast and ovarian cancer
|
Vollan, Hans Kristian Moen
|
|
2015
|
|
1 |
p. 115-127
13 p.
|
artikel
|
| 15 |
Aurora-A enhances malignant development of esophageal squamous cell carcinoma (ESCC) by phosphorylating β-catenin
|
Jin, Shunqian
|
|
2015
|
|
1 |
p. 249-259
11 p.
|
artikel
|
| 16 |
Benchmarking biology research organizations using a new, dedicated tool
|
van Harten, Willem H.
|
|
2010
|
|
1 |
p. 12-18
7 p.
|
artikel
|
| 17 |
Biomarkers in oncology drug development
|
Hodgson, Darren R.
|
|
2009
|
|
1 |
p. 24-32
9 p.
|
artikel
|
| 18 |
BMPR2 loss in fibroblasts promotes mammary carcinoma metastasis via increased inflammation
|
Pickup, Michael W.
|
|
2015
|
|
1 |
p. 179-191
13 p.
|
artikel
|
| 19 |
3-Bromopyruvate as inhibitor of tumour cell energy metabolism and chemopotentiator of platinum drugs
|
Ihrlund, Linda Strandberg
|
|
2008
|
|
1 |
p. 94-101
8 p.
|
artikel
|
| 20 |
Cancer therapeutic antibodies come of age: Targeting minimal residual disease
|
Ben-Kasus, Tsipi
|
|
2007
|
|
1 |
p. 42-54
13 p.
|
artikel
|
| 21 |
Characterization of breast precancerous lesions and myoepithelial hyperplasia in sclerosing adenosis with apocrine metaplasia
|
Celis, Julio E.
|
|
2007
|
|
1 |
p. 97-119
23 p.
|
artikel
|
| 22 |
Characterization of long non-coding RNA transcriptome in clear-cell renal cell carcinoma by next-generation deep sequencing
|
Malouf, Gabriel G.
|
|
2015
|
|
1 |
p. 32-43
12 p.
|
artikel
|
| 23 |
Chemical mapping of the colorectal cancer microenvironment via MALDI imaging mass spectrometry (MALDI-MSI) reveals novel cancer-associated field effects
|
Mirnezami, R.
|
|
2014
|
|
1 |
p. 39-49
11 p.
|
artikel
|
| 24 |
Claudin-2 is an independent negative prognostic factor in breast cancer and specifically predicts early liver recurrences
|
Kimbung, Siker
|
|
2014
|
|
1 |
p. 119-128
10 p.
|
artikel
|
| 25 |
Conference calendar
|
|
|
2008
|
|
1 |
p. 112-113
2 p.
|
artikel
|
| 26 |
Conference calendar
|
|
|
2007
|
|
1 |
p. 120-
1 p.
|
artikel
|
| 27 |
Conference calendar
|
|
|
2009
|
|
1 |
p. 84-85
2 p.
|
artikel
|
| 28 |
Corrigendum to “Expression of 19 microRNAs in glioblastoma and comparison with other brain neoplasia of grades I–III” [Mol. Oncol. 8 (2) (2014) 417–30]
|
Visani, Michela
|
|
2015
|
|
1 |
p. 334-
1 p.
|
artikel
|
| 29 |
Corrigendum to “The high mobility group A proteins contribute to thyroid cell transformation by regulating miR-603 and miR-10b expression” [Mol. Oncol. 7 (3) (Jan. 2013) 531–542]
|
Mussnich, Paula
|
|
2014
|
|
1 |
p. 159-
1 p.
|
artikel
|
| 30 |
CRABP-II methylation: A critical determinant of retinoic acid resistance of medulloblastoma cells
|
Fu, Yuan-Shan
|
|
2012
|
|
1 |
p. 48-61
14 p.
|
artikel
|
| 31 |
Deconstructing the molecular portraits of breast cancer
|
Prat, Aleix
|
|
2011
|
|
1 |
p. 5-23
19 p.
|
artikel
|
| 32 |
Determination of cell uptake pathways for tumor inhibitor lysyl oxidase propeptide
|
Ozdener, Gokhan Baris
|
|
2016
|
|
1 |
p. 1-23
23 p.
|
artikel
|
| 33 |
Development and validation of a microRNA based diagnostic assay for primary tumor site classification of liver core biopsies
|
Perell, Katharina
|
|
2015
|
|
1 |
p. 68-77
10 p.
|
artikel
|
| 34 |
DNA methylation patterns in luminal breast cancers differ from non-luminal subtypes and can identify relapse risk independent of other clinical variables
|
Kamalakaran, Sitharthan
|
|
2011
|
|
1 |
p. 77-92
16 p.
|
artikel
|
| 35 |
Dopamine D2 receptor agonists inhibit lung cancer progression by reducing angiogenesis and tumor infiltrating myeloid derived suppressor cells
|
Hoeppner, Luke H.
|
|
2015
|
|
1 |
p. 270-281
12 p.
|
artikel
|
| 36 |
Down-regulation of tumor suppressor MTUS1/ATIP is associated with enhanced proliferation, poor differentiation and poor prognosis in oral tongue squamous cell carcinoma
|
Ding, Xueqiang
|
|
2012
|
|
1 |
p. 73-80
8 p.
|
artikel
|
| 37 |
Drug development to overcome resistance to EGFR inhibitors in lung and colorectal cancer
|
Dienstmann, Rodrigo
|
|
2012
|
|
1 |
p. 15-26
12 p.
|
artikel
|
| 38 |
Dual specificity phosphatase 1 expression inversely correlates with NF-κB activity and expression in prostate cancer and promotes apoptosis through a p38 MAPK dependent mechanism
|
Gil-Araujo, Beatriz
|
|
2014
|
|
1 |
p. 27-38
12 p.
|
artikel
|
| 39 |
Dying tumor cells stimulate proliferation of living tumor cells via caspase-dependent protein kinase Cδ activation in pancreatic ductal adenocarcinoma
|
Cheng, Jin
|
|
2015
|
|
1 |
p. 105-114
10 p.
|
artikel
|
| 40 |
Ebselen abrogates TNFα induced pro-inflammatory response in glioblastoma
|
Tewari, Richa
|
|
2009
|
|
1 |
p. 77-83
7 p.
|
artikel
|
| 41 |
Editorial
|
Celis, Julio E.
|
|
2008
|
|
1 |
p. 1-
1 p.
|
artikel
|
| 42 |
Editorial
|
Celis, Julio E.
|
|
2007
|
|
1 |
p. 1-
1 p.
|
artikel
|
| 43 |
Editorial
|
Celis, Julio E.
|
|
2011
|
|
1 |
p. 1-
1 p.
|
artikel
|
| 44 |
Editorial Board
|
|
|
2016
|
|
1 |
p. ii-
1 p.
|
artikel
|
| 45 |
Editorial Board
|
|
|
2008
|
|
1 |
p. ii-
1 p.
|
artikel
|
| 46 |
Editorial Board
|
|
|
2007
|
|
1 |
p. ii-
1 p.
|
artikel
|
| 47 |
Editorial Board
|
|
|
2010
|
|
1 |
p. ii-
1 p.
|
artikel
|
| 48 |
Editorial Board
|
|
|
2009
|
|
1 |
p. ii-
1 p.
|
artikel
|
| 49 |
Editorial Board
|
|
|
2014
|
|
1 |
p. ii-
1 p.
|
artikel
|
| 50 |
Editorial Board
|
|
|
2015
|
|
1 |
p. ii-
1 p.
|
artikel
|
| 51 |
Editorial Board
|
|
|
2013
|
|
1 |
p. ii-
1 p.
|
artikel
|
| 52 |
Editorial Board
|
|
|
2011
|
|
1 |
p. iv-
1 p.
|
artikel
|
| 53 |
Editorial Board
|
|
|
2012
|
|
1 |
p. ii-
1 p.
|
artikel
|
| 54 |
EGFR mediates LPA-induced proteolytic enzyme expression and ovarian cancer invasion: Inhibition by resveratrol
|
Jeong, Kang Jin
|
|
2013
|
|
1 |
p. 121-129
9 p.
|
artikel
|
| 55 |
Epigenetics and cancer, 2nd IARC meeting, Lyon, France, 6 and 7 December 2007
|
Lambert, Marie-Pierre
|
|
2008
|
|
1 |
p. 33-40
8 p.
|
artikel
|
| 56 |
Establishing the origin of metastatic deposits in the setting of multiple primary malignancies: The role of massively parallel sequencing
|
De Mattos-Arruda, Leticia
|
|
2014
|
|
1 |
p. 150-158
9 p.
|
artikel
|
| 57 |
Europe combating cancer: The European Union's commitment to cancer research in the 6th Framework Programme
|
Jungbluth, Stefan
|
|
2007
|
|
1 |
p. 14-18
5 p.
|
artikel
|
| 58 |
Exploitation of the propulsive force of chemotherapy for improving the response to cancer immunotherapy
|
Proietti, Enrico
|
|
2012
|
|
1 |
p. 1-14
14 p.
|
artikel
|
| 59 |
Expression and hypoxic up-regulation of neuroglobin in human glioblastoma cells
|
Emara, Marwan
|
|
2009
|
|
1 |
p. 45-53
9 p.
|
artikel
|
| 60 |
Fibroblast activation protein-α, a stromal cell surface protease, shapes key features of cancer associated fibroblasts through proteome and degradome alterations
|
Koczorowska, M.M.
|
|
2016
|
|
1 |
p. 40-58
19 p.
|
artikel
|
| 61 |
Functional role of Meox2 during the epithelial cytostatic response to TGF-β
|
Valcourt, Ulrich
|
|
2007
|
|
1 |
p. 55-71
17 p.
|
artikel
|
| 62 |
Genetic and epigenetic alterations as biomarkers for cancer detection, diagnosis and prognosis
|
Herceg, Zdenko
|
|
2007
|
|
1 |
p. 26-41
16 p.
|
artikel
|
| 63 |
Genomic imbalances in endometrial adenocarcinomas – Comparison of DNA ploidy, karyotyping and comparative genomic hybridization
|
Kildal, Wanja
|
|
2012
|
|
1 |
p. 98-107
10 p.
|
artikel
|
| 64 |
Genomic instability and copy-number heterogeneity of chromosome 19q, including the kallikrein locus, in ovarian carcinomas
|
Bayani, Jane
|
|
2011
|
|
1 |
p. 48-60
13 p.
|
artikel
|
| 65 |
Genomic signatures for paclitaxel and gemcitabine resistance in breast cancer derived by machine learning
|
Dorman, Stephanie N.
|
|
2016
|
|
1 |
p. 85-100
16 p.
|
artikel
|
| 66 |
Glioma-derived macrophage migration inhibitory factor (MIF) promotes mast cell recruitment in a STAT5-dependent manner
|
Põlajeva, Jelena
|
|
2014
|
|
1 |
p. 50-58
9 p.
|
artikel
|
| 67 |
HBx genotype D represses GSTP1 expression and increases the oxidative level and apoptosis in HepG2 cells
|
Niu, Dandan
|
|
2009
|
|
1 |
p. 67-76
10 p.
|
artikel
|
| 68 |
High HER2 protein levels correlate with increased survival in breast cancer patients treated with anti-HER2 therapy
|
Nuciforo, Paolo
|
|
2016
|
|
1 |
p. 138-147
10 p.
|
artikel
|
| 69 |
High-throughput screens identify microRNAs essential for HER2 positive breast cancer cell growth
|
Leivonen, Suvi-Katri
|
|
2014
|
|
1 |
p. 93-104
12 p.
|
artikel
|
| 70 |
Infiltrating T cells promote prostate cancer metastasis via modulation of FGF11→miRNA-541→androgen receptor (AR)→MMP9 signaling
|
Hu, Shuai
|
|
2015
|
|
1 |
p. 44-57
14 p.
|
artikel
|
| 71 |
Integrated miRNA and mRNA profiling of tumor-educated macrophages identifies prognostic subgroups in estrogen receptor-positive breast cancer
|
Bleckmann, Annalen
|
|
2015
|
|
1 |
p. 155-166
12 p.
|
artikel
|
| 72 |
Integrative analysis of cancer imaging readouts by networks
|
Dominietto, Marco
|
|
2015
|
|
1 |
p. 1-16
16 p.
|
artikel
|
| 73 |
Interleukin-33 predicts poor prognosis and promotes ovarian cancer cell growth and metastasis through regulating ERK and JNK signaling pathways
|
Tong, Xiaoguang
|
|
2016
|
|
1 |
p. 113-125
13 p.
|
artikel
|
| 74 |
Lack of independent prognostic and predictive value of centromere 17 copy number changes in breast cancer patients with known HER2 and TOP2A status
|
Nielsen, Kirsten Vang
|
|
2012
|
|
1 |
p. 88-97
10 p.
|
artikel
|
| 75 |
Lysophosphatidic acid (LPA)-induced vasodilator-stimulated phosphoprotein mediates lamellipodia formation to initiate motility in PC-3 prostate cancer cells
|
Hasegawa, Yutaka
|
|
2008
|
|
1 |
p. 54-69
16 p.
|
artikel
|
| 76 |
Meeting the global demands of epidemiologic transition – The indispensable role of cancer prevention
|
Franceschi, Silvia
|
|
2013
|
|
1 |
p. 1-13
13 p.
|
artikel
|
| 77 |
MEK inhibitors reverse resistance in epidermal growth factor receptor mutation lung cancer cells with acquired resistance to gefitinib
|
Huang, Ming-Hung
|
|
2013
|
|
1 |
p. 112-120
9 p.
|
artikel
|
| 78 |
Methylation profiling with a panel of cancer related genes: Association with estrogen receptor, TP53 mutation status and expression subtypes in sporadic breast cancer
|
Rønneberg, Jo Anders
|
|
2011
|
|
1 |
p. 61-76
16 p.
|
artikel
|
| 79 |
Mice thrive without Cdk4 and Cdk2
|
Barrière, Cédric
|
|
2007
|
|
1 |
p. 72-83
12 p.
|
artikel
|
| 80 |
miR-203 induces oxaliplatin resistance in colorectal cancer cells by negatively regulating ATM kinase
|
Zhou, Yunfei
|
|
2014
|
|
1 |
p. 83-92
10 p.
|
artikel
|
| 81 |
Mitotic arrest and slippage induced by pharmacological inhibition of Polo-like kinase 1
|
Raab, Monika
|
|
2015
|
|
1 |
p. 140-154
15 p.
|
artikel
|
| 82 |
Molecular aspects of tumour hypoxia
|
Rademakers, Saskia E.
|
|
2008
|
|
1 |
p. 41-53
13 p.
|
artikel
|
| 83 |
MTA1 regulates higher-order chromatin structure and histone H1-chromatin interaction in-vivo
|
Liu, Jian
|
|
2015
|
|
1 |
p. 218-235
18 p.
|
artikel
|
| 84 |
mTORC1 and DNA-PKcs as novel molecular determinants of sensitivity to Chk1 inhibition
|
Massey, Andrew J.
|
|
2016
|
|
1 |
p. 101-112
12 p.
|
artikel
|
| 85 |
Multifunctional protein APPL2 contributes to survival of human glioma cells
|
Pyrzynska, Beata
|
|
2013
|
|
1 |
p. 67-84
18 p.
|
artikel
|
| 86 |
Mutant p53 targeting by the low molecular weight compound STIMA-1
|
Zache, Nicole
|
|
2008
|
|
1 |
p. 70-80
11 p.
|
artikel
|
| 87 |
NESH protein expression switches to the adverse effect of imatinib mesylate
|
Matsuda, Satoru
|
|
2008
|
|
1 |
p. 16-19
4 p.
|
artikel
|
| 88 |
New Members of the Editorial Board - Personal Profiles
|
|
|
2011
|
|
1 |
p. 2-4
3 p.
|
artikel
|
| 89 |
New specific molecular targets for radio-chemotherapy of rectal cancer
|
Snipstad, Kristin
|
|
2010
|
|
1 |
p. 52-64
13 p.
|
artikel
|
| 90 |
N-Myc is a downstream target of RET signaling and is required for transcriptional regulation of p18Ink4c by the transforming mutant RETC634R
|
Kulkarni, Mandar V.
|
|
2011
|
|
1 |
p. 24-35
12 p.
|
artikel
|
| 91 |
PARP inhibitor olaparib increases the oncolytic activity of dl922-947 in in vitro and in vivo model of anaplastic thyroid carcinoma
|
Passaro, Carmela
|
|
2015
|
|
1 |
p. 78-92
15 p.
|
artikel
|
| 92 |
p53-Based strategy to reduce hematological toxicity of chemotherapy: A proof of principle study
|
Ha, Chul S.
|
|
2016
|
|
1 |
p. 148-156
9 p.
|
artikel
|
| 93 |
PCDH24-induced contact inhibition involves downregulation of β-catenin signaling
|
Ose, Rui
|
|
2009
|
|
1 |
p. 54-66
13 p.
|
artikel
|
| 94 |
Personalised pathway analysis reveals association between DNA repair pathway dysregulation and chromosomal instability in sporadic breast cancer
|
Liu, Chao
|
|
2016
|
|
1 |
p. 179-193
15 p.
|
artikel
|
| 95 |
Personal Profiles
|
|
|
2008
|
|
1 |
p. 2-4
3 p.
|
artikel
|
| 96 |
Personal Profiles
|
|
|
2007
|
|
1 |
p. 2-7
6 p.
|
artikel
|
| 97 |
Personal Profiles
|
|
|
2009
|
|
1 |
p. 1-2
2 p.
|
artikel
|
| 98 |
Pharmacologically enhanced expression of GPNMB increases the sensitivity of melanoma cells to the CR011-vcMMAE antibody-drug conjugate
|
Qian, Xiaozhong
|
|
2008
|
|
1 |
p. 81-93
13 p.
|
artikel
|
| 99 |
Plasma microRNAs predicting clinical outcome in metastatic colorectal cancer patients receiving first-line oxaliplatin-based treatment
|
Kjersem, J.B.
|
|
2014
|
|
1 |
p. 59-67
9 p.
|
artikel
|
| 100 |
Polymorphic variations in the FANCA gene in high-risk non-BRCA1/2 breast cancer individuals from the French Canadian population
|
Litim, Nadhir
|
|
2013
|
|
1 |
p. 85-100
16 p.
|
artikel
|
| 101 |
Potential biomarkers of long-term benefit from single-agent trastuzumab or lapatinib in HER2-positive metastatic breast cancer
|
Montemurro, Filippo
|
|
2014
|
|
1 |
p. 20-26
7 p.
|
artikel
|
| 102 |
Preclinical evaluation of bortezomib/dipyridamole novel combination as a potential therapeutic modality for hematologic malignancies
|
Goda, Ahmed E.
|
|
2015
|
|
1 |
p. 309-322
14 p.
|
artikel
|
| 103 |
Profile: Professor Axel Ullrich
|
Cheng, Margaret Harris
|
|
2009
|
|
1 |
p. 3-4
2 p.
|
artikel
|
| 104 |
Prognostic value of Bcl-2 in breast cancer patients treated with neoadjuvant anthracycline based chemotherapy
|
Vargas-Roig, Laura M.
|
|
2008
|
|
1 |
p. 102-111
10 p.
|
artikel
|
| 105 |
Proteasome inhibition in cancer is associated with enhanced tumor targeting by the adeno-associated virus/phage
|
Przystal, Justyna M.
|
|
2013
|
|
1 |
p. 55-66
12 p.
|
artikel
|
| 106 |
4-protein signature predicting tamoxifen treatment outcome in recurrent breast cancer
|
De Marchi, Tommaso
|
|
2016
|
|
1 |
p. 24-39
16 p.
|
artikel
|
| 107 |
Report on EU–USA Workshop: How Systems Biology Can Advance Cancer Research (27 October 2008)
|
Aebersold, Ruedi
|
|
2009
|
|
1 |
p. 9-17
9 p.
|
artikel
|
| 108 |
Resistance to BRAF inhibitors induces glutamine dependency in melanoma cells
|
Baenke, Franziska
|
|
2016
|
|
1 |
p. 73-84
12 p.
|
artikel
|
| 109 |
Secretome and degradome profiling shows that Kallikrein-related peptidases 4, 5, 6, and 7 induce TGFβ-1 signaling in ovarian cancer cells
|
Shahinian, Hasmik
|
|
2014
|
|
1 |
p. 68-82
15 p.
|
artikel
|
| 110 |
Sensitivity of plasma BRAFmutant and NRASmutant cell-free DNA assays to detect metastatic melanoma in patients with low RECIST scores and non-RECIST disease progression
|
Chang, Gregory A.
|
|
2016
|
|
1 |
p. 157-165
9 p.
|
artikel
|
| 111 |
Serum metabolomic profiles evaluated after surgery may identify patients with oestrogen receptor negative early breast cancer at increased risk of disease recurrence. Results from a retrospective study
|
Tenori, Leonardo
|
|
2015
|
|
1 |
p. 128-139
12 p.
|
artikel
|
| 112 |
Serum N-glycan analysis in breast cancer patients – Relation to tumour biology and clinical outcome
|
Haakensen, Vilde D.
|
|
2016
|
|
1 |
p. 59-72
14 p.
|
artikel
|
| 113 |
SNPs associated with molecular subtypes of breast cancer: On the usefulness of stratified Genome-wide Association Studies (GWAS) in the identification of novel susceptibility loci
|
Kristensen, Vessela N.
|
|
2008
|
|
1 |
p. 12-15
4 p.
|
artikel
|
| 114 |
Somatic evolution of head and neck cancer – Biological robustness and latent vulnerability
|
Masuda, Muneyuki
|
|
2013
|
|
1 |
p. 14-28
15 p.
|
artikel
|
| 115 |
Spatio-temporal composition of the mitotic Chromosomal Passenger Complex detected using in situ proximity ligation assay
|
Vuoriluoto, Mariaana
|
|
2011
|
|
1 |
p. 105-111
7 p.
|
artikel
|
| 116 |
Subtype-specific response to bevacizumab is reflected in the metabolome and transcriptome of breast cancer xenografts
|
Borgan, Eldrid
|
|
2013
|
|
1 |
p. 130-142
13 p.
|
artikel
|
| 117 |
Synergistic induction of apoptosis by the Bcl-2 inhibitor ABT-737 and imatinib mesylate in gastrointestinal stromal tumor cells
|
Reynoso, David
|
|
2011
|
|
1 |
p. 93-104
12 p.
|
artikel
|
| 118 |
Systems pathology: A critical review
|
Costa, Jose
|
|
2012
|
|
1 |
p. 27-32
6 p.
|
artikel
|
| 119 |
‘Tackling cancer in the EU: The role of innovation’
|
Andrejevs, Georgs
|
|
2009
|
|
1 |
p. 18-23
6 p.
|
artikel
|
| 120 |
Targeted proteomic strategy for clinical biomarker discovery
|
Schiess, Ralph
|
|
2009
|
|
1 |
p. 33-44
12 p.
|
artikel
|
| 121 |
Targeted Therapies: The Rare Cancer Paradigm
|
Pierotti, Marco A.
|
|
2010
|
|
1 |
p. 19-37
19 p.
|
artikel
|
| 122 |
Targeting BRCA1-BER deficient breast cancer by ATM or DNA-PKcs blockade either alone or in combination with cisplatin for personalized therapy
|
Albarakati, Nada
|
|
2015
|
|
1 |
p. 204-217
14 p.
|
artikel
|
| 123 |
The clinical significance of inflammatory cytokines in primary cell culture in endometrial carcinoma
|
Smith, Harriet O.
|
|
2013
|
|
1 |
p. 41-54
14 p.
|
artikel
|
| 124 |
The co-chaperone p23 promotes prostate cancer motility and metastasis
|
Querol Cano, Laia
|
|
2015
|
|
1 |
p. 295-308
14 p.
|
artikel
|
| 125 |
The estrogen receptor alpha-derived peptide ERα17p (P295-T311) exerts pro-apoptotic actions in breast cancer cells in vitro and in vivo, independently from their ERα status
|
Pelekanou, Vassiliki
|
|
2011
|
|
1 |
p. 36-47
12 p.
|
artikel
|
| 126 |
The immune-related role of BRAF in melanoma
|
Tomei, Sara
|
|
2015
|
|
1 |
p. 93-104
12 p.
|
artikel
|
| 127 |
The morphologies of breast cancer cell lines in three-dimensional assays correlate with their profiles of gene expression
|
Kenny, Paraic A.
|
|
2007
|
|
1 |
p. 84-96
13 p.
|
artikel
|
| 128 |
The p53/mouse double minute 2 homolog complex deregulation in merlin-deficient tumours
|
Ammoun, Sylwia
|
|
2015
|
|
1 |
p. 236-248
13 p.
|
artikel
|
| 129 |
The role of histone deacetylases (HDACs) in human cancer
|
Ropero, Santiago
|
|
2007
|
|
1 |
p. 19-25
7 p.
|
artikel
|
| 130 |
The Stockholm Declaration
|
Ringborg, Ulrik
|
|
2008
|
|
1 |
p. 10-11
2 p.
|
artikel
|
| 131 |
The Stockholm declaration signals a cultural change in Europe's approach to cancer research. An interview with Ulrik Ringborg
|
Brown, Hannah
|
|
2008
|
|
1 |
p. 8-9
2 p.
|
artikel
|
| 132 |
The unified approach: Meeting the cancer challenges of the next decade
|
Fricker, Janet
|
|
2010
|
|
1 |
p. 1-8
8 p.
|
artikel
|
| 133 |
The US comprehensive cancer centers in perspective
|
Loewenberg, Samuel
|
|
2010
|
|
1 |
p. 9-11
3 p.
|
artikel
|
| 134 |
Tivantinib (ARQ 197) efficacy is independent of MET inhibition in non-small-cell lung cancer cell lines
|
Calles, Antonio
|
|
2015
|
|
1 |
p. 260-269
10 p.
|
artikel
|
| 135 |
Topoisomerase IIα-dependent induction of a persistent DNA damage response in response to transient etoposide exposure
|
Soubeyrand, Sébastien
|
|
2010
|
|
1 |
p. 38-51
14 p.
|
artikel
|
| 136 |
Topoisomerase 1(TOP1) gene copy number in stage III colorectal cancer patients and its relation to prognosis
|
Rømer, Maria Unni
|
|
2013
|
|
1 |
p. 101-111
11 p.
|
artikel
|
| 137 |
Towards individualized cancer therapy: Challenges and prospects
|
Hutchinson, Ezzie
|
|
2014
|
|
1 |
p. 1-8
8 p.
|
artikel
|
| 138 |
Transcriptional profiling of dividing tumor cells detects intratumor heterogeneity linked to cell proliferation in a brain tumor model
|
Endaya, Berwini B.
|
|
2016
|
|
1 |
p. 126-137
12 p.
|
artikel
|
| 139 |
Translational cancer research in Europe
|
Fricker, Janet
|
|
2007
|
|
1 |
p. 8-10
3 p.
|
artikel
|
| 140 |
Translational cancer research in the USA
|
Brown, Hannah
|
|
2007
|
|
1 |
p. 11-13
3 p.
|
artikel
|
| 141 |
Trends in the global funding and activity of cancer research
|
Eckhouse, Seth
|
|
2008
|
|
1 |
p. 20-32
13 p.
|
artikel
|
| 142 |
Turning the Stockholm Declaration into reality: Creating a world-class infrastructure for cancer research in Europe
|
Brown, Hannah
|
|
2009
|
|
1 |
p. 5-8
4 p.
|
artikel
|
| 143 |
uPA and uPAR shRNA inhibit angiogenesis via enhanced secretion of SVEGFR1 independent of GM-CSF but dependent on TIMP-1 in endothelial and glioblastoma cells
|
Raghu, Hari
|
|
2012
|
|
1 |
p. 33-47
15 p.
|
artikel
|
| 144 |
Up-regulated Proteins in the Fluid Bathing the Tumour Cell Microenvironment as Potential Serological Markers for Early Detection of Cancer of the Breast
|
Gromov, Pavel
|
|
2010
|
|
1 |
p. 65-89
25 p.
|
artikel
|
| 145 |
V-ATPase inhibition overcomes trastuzumab resistance in breast cancer
|
von Schwarzenberg, Karin
|
|
2014
|
|
1 |
p. 9-19
11 p.
|
artikel
|
| 146 |
Volitinib, a potent and highly selective c-Met inhibitor, effectively blocks c-Met signaling and growth in c-MET amplified gastric cancer patient-derived tumor xenograft models
|
Gavine, Paul R.
|
|
2015
|
|
1 |
p. 323-333
11 p.
|
artikel
|
Tijdschrift beschrijving